← Back to Screener
Cryo-Cell International Inc. (CCEL)
Price$3.50
Value ScoreB
Growth ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-25.18%
Price vs S&P 500 (4W)-5.72%
VGM Score44.85
Market Capitalization$28.19M
P/E Ratio (Annual)69.51x
Indicated Dividend Yield (Annual)11.43%
All Metrics
P/CF (Annual)5.15x
Book Value / Share (Quarterly)$0.52
P/TBV (Annual)40.23x
Revenue Growth (3Y)1.33%
Cash Flow / Share (Quarterly)$-0.04
Payout Ratio (TTM)1102.49%
Price vs S&P 500 (YTD)-9.28%
Gross Margin (TTM)77.47%
Net Profit Margin (TTM)-8.52%
EPS (TTM)$-0.33
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-0.33
Revenue Growth (5Y)0.27%
EPS (Annual)$-0.30
Dividend / Share (Annual)$0.40
ROI (Annual)34.26%
Gross Margin (Annual)76.63%
Net Profit Margin (5Y Avg)-4.09%
Cash / Share (Quarterly)$0.36
Revenue Growth QoQ (YoY)-3.59%
EPS Growth (5Y)-29.04%
P/E Normalized (Annual)69.51x
ROA (Last FY)-3.94%
Revenue Growth TTM (YoY)-2.56%
EBITD / Share (TTM)$0.58
ROE (5Y Avg)48.39%
Operating Margin (TTM)0.61%
Cash Flow / Share (Annual)$0.65
P/B Ratio6.40x
P/B Ratio (Quarterly)10.59x
Net Income / Employee (Annual)$-33,700
EV / Revenue (TTM)1.16x
Net Interest Coverage (TTM)0.19x
ROA (TTM)-4.26%
EPS Growth QoQ (YoY)-83.19%
EV / EBITDA (TTM)7.69x
EPS Incl Extra (Annual)$-0.30
Current Ratio (Annual)0.59x
Quick Ratio (Quarterly)0.58x
3-Month Avg Trading Volume0.01M
52-Week Price Return-30.14%
EV / Free Cash Flow (Annual)6.91x
Revenue / Employee (TTM)$434,500
Tangible BV / Share (Quarterly)$0.34
P/S Ratio (Annual)0.89x
Asset Turnover (Annual)0.51x
52-Week High$6.35
Operating Margin (5Y Avg)0.07%
EPS Excl Extra (Annual)$-0.30
CapEx CAGR (5Y)18.18%
26-Week Price Return-13.79%
Quick Ratio (Annual)0.54x
13-Week Price Return6.87%
Total Debt / Equity (Annual)0.45x
Current Ratio (Quarterly)0.62x
Enterprise Value$36.26M
Revenue / Share Growth (5Y)0.44%
Asset Turnover (TTM)0.50x
Revenue / Employee (Annual)$438,400
Inventory Turnover (Annual)13.83x
Pretax Margin (Annual)-7.40%
Cash / Share (Annual)$0.41
3-Month Return Std Dev68.00%
Gross Margin (5Y Avg)72.95%
Net Income / Employee (TTM)$-37,000
EBITDA CAGR (5Y)-28.83%
EBITDA Interim CAGR (5Y)-5.46%
ROE (Last FY)49.79%
Net Interest Coverage (Annual)0.08x
EPS Basic Excl Extra (Annual)$-0.30
P/FCF (TTM)4.56x
Receivables Turnover (TTM)4.46x
EV / Free Cash Flow (TTM)5.89x
Total Debt / Equity (Quarterly)0.08x
EPS Incl Extra (TTM)$-0.33
Receivables Turnover (Annual)4.46x
ROI (TTM)28.47%
P/S Ratio (TTM)0.90x
Pretax Margin (5Y Avg)-4.26%
Revenue / Share (Annual)$3.91
Tangible BV / Share (Annual)$0.31
Forward P/E31.82x
Free OCF CAGR (5Y)-8.91%
Price vs S&P 500 (52W)-57.18%
Year-to-Date Return1.75%
5-Day Price Return3.86%
EPS Normalized (Annual)$-0.30
ROA (5Y Avg)-2.23%
Net Profit Margin (Annual)-7.70%
Month-to-Date Return3.86%
Cash Flow / Share (TTM)$0.47
EBITD / Share (Annual)$0.15
EPS Growth (3Y)-41.85%
Operating Margin (Annual)1.53%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)4.46x
ROI (5Y Avg)45.26%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.33
P/TBV (Quarterly)16.12x
Payout Ratio (Annual)502.50%
P/B Ratio (Annual)25.24x
Dividend / Share (TTM)$0.55
Inventory Turnover (TTM)12.96x
Pretax Margin (TTM)-8.95%
Book Value / Share (Annual)$0.49
Price vs S&P 500 (13W)-3.63%
Net Margin Growth (5Y)-29.43%
Dividend Yield (TTM)15.76%
Beta0.56x
P/FCF (Annual)5.37x
Revenue / Share (TTM)$3.88
ROE (TTM)38.23%
52-Week Low$2.72
vGradeB
gGradeF
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.01est. -0.03
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
2.17
2.17
2.17
2.17
Industry Peers — Health Services(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CCELCryo-Cell International Inc. | B | F | C | $3.50 |
| DVADaVita Inc. | C | C | B | $192.16 |
| FMSFresenius Medical Care AG | A | D | C | $22.03 |
| SHCSotera Health Company Common Stock | D | B | C | $15.62 |
| PGNYProgyny, Inc. Common Stock | C | B | B | $25.86 |
| AGLagilon health, inc. | B | C | A | $96.85 |
| MCTACharming Medical Limited Class A Ordinary Shares | F | F | A | $29.36 |
| VMDViemed Healthcare, Inc. Common Shares | C | C | B | $9.97 |
| QIPTQuipt Home Medical Corp. Ordinary Shares | B | B | B | $0.00 |
| PARKPark Dental Partners, Inc. Common Stock | B | C | C | $18.96 |
| OAKUOak Woods Acquisition Corporation Class A Ordinary Shares | — | F | B | $0.00 |
About
Cryo-Cell International Inc specializes in the collection, processing, and cryogenic storage of umbilical cord blood and tissue stem cells for both private family banking and public banking applications. The company operates through three segments: private cellular banking services, public cord blood banking, and its PrepaCyte CB processing technology platform. Revenue is generated from processing fees, testing services, and long-term cryogenic storage.